Abstract
Children treated for pediatric blood cancers, such as leukemia and lymphoma, are at risk of experiencing cognitive and learning challenges, or late effects, following medical treatment. As such, pediatric neuropsychological evaluations have become a standard component of follow-up care for children following treatment of blood cancers. This chapter provides a general overview of pediatric blood cancers, including pathology, prevalence, and treatment. This sets the stage for a deeper dive into the ways in which the most common cancer treatments, including chemotherapy, radiation, and hematopoietic cell transplantation, can negatively impact a child’s developing nervous system and lead to neuropsychological late effects. Lastly, clinical considerations are reviewed, including methods for monitoring and assessing neuropsychological functioning, common neuropsychological impairments, and interventions and accommodations used to address late effects in children treated for blood cancers.